4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-23-053820
Options or other derivatives
- Chief Financial Officer acquired 13,832 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Prasad Raju Chief Financial Officer | 2023-10-13 | Grant or award · Stock Option (Right to Buy) | +13,832 | 13,832 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…